Quick Answer
SELLAS Life Sciences Group, Inc. reported Net Income of -$26.86 million for fiscal year 2025.
SELLAS Life Sciences Group, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$26.86M | +13.0% |
| 2024 | -$30.88M | +17.3% |
| 2023 | -$37.34M | +9.6% |
| 2022 | -$41.30M | -99.5% |
| 2021 | -$20.70M | -23.5% |
| 2020 | -$16.76M | +13.1% |
| 2019 | -$19.29M | +30.3% |
| 2018 | -$27.67M | -16.5% |
| 2017 | -$23.75M | -34.3% |
| 2016 | -$17.68M | +72.3% |
| 2015 | -$63.90M | -74.6% |
| 2014 | -$36.61M | +52.3% |
| 2013 | -$76.68M | -119.3% |
| 2012 | -$34.97M | -204.5% |
| 2011 | -$11.48M | +4.2% |
| 2010 | -$11.99M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$6.79M | +4.5% | -2.9% |
| June 30, 2025 | -$6.60M | +11.6% | -13.6% |
| March 31, 2025 | -$5.81M | +39.2% | +18.2% |
| September 30, 2024 | -$7.11M | +23.3% | +4.8% |
| June 30, 2024 | -$7.47M | +15.5% | +21.9% |
| March 31, 2024 | -$9.57M | +13.8% | -3.2% |
| September 30, 2023 | -$9.27M | -32.0% | -4.8% |
| June 30, 2023 | -$8.84M | -5.1% | +20.3% |
- SELLAS Life Sciences Group, Inc. showed an increase of +13.0% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, SELLAS Life Sciences Group, Inc.’s net income has declined by 124.0% (from -$11.99 million to -$26.86 million).
- The most recent figure is from SELLAS Life Sciences Group, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: